AKT1 and cervical cancer: Here, we show that the inhibition of E6/E7 expression in hypoxic cervical cancer cells is mediated by the hypoxia-induced activation of the PI3K/mechanistic target of rapamycin (mTOR) complex 2 (mTORC2)/AKT pathway.